Post on 04-May-2019
transcript
COMPANY UPDATEFY 2017 AUDITED
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK
This presentation is made to provide information. No representation or warranty ismade as to the fairness, accuracy, completeness or correctness of the information,opinions and conclusions contained within this presentation. All information includingbusiness forward plans in this presentation should not be considered as arecommendation in relation to holding purchasing or selling shares in any jurisdiction.No copy or use of this presentation should occur without the permission of PT INDUSTRIJAMU DAN FARMASI SIDO MUNCUL TBK.
Disclaimer
INTRODUCTION
FINANCIAL HIGHLIGHT
DESCRIPTION 2016 2017 ∆AUDITED AUDITED
Net Sales 2,561,806 2,573,840 0.5%Operating Income 559,443 625,738 11.9%
% margin 21.8% 24.3%Net Income 480,525 533,799 11.1%
% margin 18.8% 20.7%
Total Assets 2,987,614 3,158,198 5.7%Total Liabilities 229,729 262,333 14.2%Total Equity 2,757,885 2,895,865 5.0%
Working Capital 1,578,439 1,420,394 -10.0%
Current Ratio 8.3 7.8 -0.5Cash Conversion Cycle 85 96 11Debt to Equity 0.0% 0.0% 0.0%
PROFILE
VISIONTo become a leading herbal medicine, health food & drinks, and herbal ingredient
processing company which can benefit the community and environment
MISSION To develop rational, safe and honest herbal-based products based on research. To continuously develop research in herbal medicines. To assist and encourage the government, education institutions, and medical sector to
play a more important role in research and development of herbal medicines andmedication .
To increase community awareness of them importance of maintaining health throughhealthy living pattern, use of natural substance, and naturopathy medication.
To implement intensive corporate social responsibility (CSR) To manage an environmental-oriented company. To become a world class herbal medicine company
BUSINESS FIELDSHerbal Medicine & Pharmaceutical
MILESTONES
1970A limited
partnership wasestablished
under the nameCV. Industri Jamu
& Farmasi SidoMuncul
1975PT. Industri Jamu& Farmasi Sido
Munculestablished
1984The factory was
moved toKaligawe,Semarang
2000Inaugurated anew factory in
Klepu, Ungaran
2010Herbal extraction
factory groundbreaking
2013IPO on the
Indonesia StockExchange
2014Acquisition of PT
Berlico MuliaFarma
1951A small businesswas establishedunder the name
Sido Munculwhich has the
meaning of“Dream Comes
True”
EVENT: 2017 - NOW
CORPORATE STRUCTURE
SUBSIDIARIES
No. Subsidiaries EquityParticipation
Year ofParticipation
BusinessLines
Operational
1 PT Muncul Mekar 99,99% 2012 Trading A distribution company of allSido Muncul productsthrough an extensivedistribution network spreadall over Indonesia.
2 PT Semarang HerbalIndo Plant
99,99% 2012 HerbExtraction
A raw material extractionfactory
3 PT Berlico MuliaFarma
99,99% 2014 Pharmacy A pharmaceutical company,producing OTC and Ethicalproducts
4 Muncul NigeriaLimited
99,00% 2018 Export New entity in Nigeria, whichwill support marketingefforts in expanding exportsales in Nigeria.
BOARD MEMBERS
BOARD OF DIRECTORS
Jonatha Sofyan Hidayat President DirectorIrwan Hidayat DirectorDavid Hidayat DirectorVenancia Sri Indrijati W. DirectorCarlo Lukman Windarto Independent Director
BOARD OF COMMISSIONERS
Sigit Hartojo Hadi Santoso President Commissioner
Johan Hidayat CommissionerEric Marnandus Independent CommissionerRonnie Behar Independent Commissioner
BUSINESS OVERVIEW
PRODUCT PORTFOLIO
HERBAL&
SUPPLEMENT
FOOD&
BEVERAGES
PHARMACEUTICAL
DISTRIBUTION NETWORK
INTERNATIONAL BUSINESS
SIDO MUNCUL PRODUCTS ARE EXPORTEDTO SEVERAL COUNTRIES Malaysia Singapore Brunei Darussalam Hong Kong Taiwan Korea Selatan Australia Saudi Arabia Pakistan Nigeria Togo USA Canada
FINANCIAL OVERVIEW
2016 2017
SALES (IDR Bn)
SALES MIX
Consolidated+0.5%
Herbal &Supplement+11.3%
Food &Beverages-17.5%
Pharma-17.5%
Herbal &Supplement
66%
Food &Beverage
31%
Pharma3%
2,561.8 2,573.8
559626
21.8% 24.3%
2016 2017
Op. Profit % to NS
OPERATING PERFORMANCE (IDR Bn)
GROSS PROFIT
OPEX to Net Sales
14.5% 14.2%
5.4% 6.7%
2016 2017
%OPEX to NSMarketing Exp. G&A Exp.
OPERATING PROFIT
Consolidated+11.9%
1,068 1,162
41.7% 45.1%
2016 2017Gross Profit % to NS
Consolidated+8.8%
NET EARNINGS (IDR Bn)
NET INCOME
481534
18.8% 20.7%
2016 2017
Net Income % to NS
Consolidated+11.1%
PROFITABILITY
DIVIDEND PER SHARE
16.1% 16.9%
17.4% 18.4%
2016 2017
ROA ROE
27 24 25 26
100%86% 85% 82%
2013 2014 2015 2016
DPS %payout
FINANCIAL POSITION (IDR Bn)
ASSETS & EQUITY
2,955 2,820 2,796 2,988 3,158
2,614 2,625 2,598 2,758 2,896
2013 2014 2015 2016 2017
ASSETS EQUITY
0.0 0.0 0.0 0.0 0.0
2013 2014 2015 2016 2017
DEBT POITION
CASH CYCLE
79 7886 85
96
2013 2014 2015 2016 2017
BUSINESS PROSPECTS
BUSINESS PROSPECTS
In early of 2018, Muncul NigeriaLimited established to increase thepotential export market in Africaarea.
New production facility of liquid herbalmedicine, very modern and fullyautomated.
Production capacity will rise 100% whichwill be used to produce other kinds ofherbal products.
PT INDUSTRI JAMU DAN FARMASISIDO MUNCUL TBK.
HEAD OFFICE:Gedung Menara Suara Merdeka, Lt. 16Jalan Pandanaran No. 30Semarang - Indonesia
FACTORY:Jl. Soekarno Hatta, Km. 28Kec. Bergas – KlepuSemarang – Indonesia
BRANCH OFFICE:
Grha Muncul MekarJl. Panjang Arteri Kelapa Dua, No. 27Kebon JerukJakarta Barat - Indonesia
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
in IDR Mn 2017 2016AUDITED AUDITED
Current AssetsCash and Cash Equivalents 902,852 1,002,135 -9.9%Trade Receivables 427,322 367,204 16.4%Inventories - Net 267,915 317,082 -15.5%Others 30,812 107,704 -71.4%Total Current Assets 1,628,901 1,794,125 -9.2%Total Non-current Assets 1,529,297 1,193,489 28.1%TOTAL ASSETS 3,158,198 2,987,614 5.7%Current LiabilitiesTrade Payables 124,898 177,864 -29.8%Others 83,609 37,822 121.1%Total Current Liabilities 208,507 215,686 -3.3%Total Non-current Liabilites 53,826 14,043 283.3%TOTAL LIABILITIES 262,333 229,729 14.2%EQUITYEquity Attributable to Owners of the Parent Entity 2,895,858 2,757,878 5.0%Non-controlling Interest 7 7 0.0%TOTAL EQUITY 2,895,865 2,757,885 5.0%TOTAL LIABILITIES AND EQUITY 3,158,198 2,987,614 5.7%
∆
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
in IDR Mn 2017 2016AUDITED AUDITED
Sales 2,573,840 2,561,806 0.5%Cost of Good Sold 1,411,881 1,494,142 -5.5%Gross Profit 1,161,959 1,067,664 8.8%
% Margin 45.1% 41.7% 3.5%Selling Expenses 364,203 370,195 -1.6%General and Administrative Expenses 172,018 138,026 24.6%Operating Income 625,738 559,443 11.9%
% Margin 24.3% 21.8% 2.5%Other Finance Income 42,241 50,945 -17.1%Other Finance Expenses 588 140 320.0%Other Operating Income 17,436 23,381 -25.4%Other Operating Expenses 2,938 4,547 -35.4%Income Before Tax 681,889 629,082 8.4%
% Margin 26.5% 24.6% 1.9%Income Tax Expenses 148,090 148,557 -0.3%Net Income for the Year 533,799 480,525 11.1%
% Margin 20.7% 18.8% 2.0%Other Comprehensive Income (Loss) (11,080) (8,803) 25.9%Total Comprehensive Income for the Year 522,719 471,722 10.8%
% Margin 20.3% 18.4% 1.9%
∆
CONSOLIDATED STATEMENTS OF CASH FLOWS
in IDR Mn 2017 2016AUDITED AUDITED
Cash Flows From Operating Activities 640,695 462,656Cash Flows From Investing Activities (350,264) 9,402Cash Flows From Financing Activities (384,739) (312,151)
Net Increase (Decrease) in Cash and Cash Equivalents (94,308) 159,907Effect of Changes in Foreign Exchange Rate 25 253Cash and Cash Equivalents At the Beginning of the Year 997,135 836,975Cash and Cash Equivalents At the End of the Year 902,852 997,135